Global Newborn and Prenatal Genetic Testing Supply, Demand and Key Producers, 2026-2032

The global Newborn and Prenatal Genetic Testing market size is expected to reach $ 6665 million by 2032, rising at a market growth of 9.0% CAGR during the forecast period (2026-2032).

Newborn and Prenatal Genetic Testing refers to the set of genetic tests performed before birth and shortly after birth to assess the risk or presence of inherited and congenital conditions. It includes prenatal tests that evaluate fetal genetic risk during pregnancy and newborn tests that screen infants for serious conditions that may not be clinically apparent at delivery, with results used to guide confirmatory diagnostics, treatment decisions, and long term follow up care.

The newborn and prenatal genetic testing market represents a continuum of early life risk identification that links reproductive planning, pregnancy management, and postnatal prevention into a single diagnostics value chain. The market combines policy anchored newborn screening programs with more commercially flexible prenatal testing, creating a hybrid structure where growth is driven both by guideline and reimbursement decisions and by consumer and clinician preference for earlier and more informative results. Competitive advantage increasingly depends on test performance, service reliability, counseling and clinical integration, and the ability to coordinate follow up pathways, because the economic value of testing is realized only when results trigger timely clinical action. Over time, market expansion is likely to be propelled by broader adoption of non invasive methods, richer test menus, and tighter integration with digital care workflows, while cost effectiveness scrutiny and ethical governance will shape the pace and direction of innovation.

This report studies the global Newborn and Prenatal Genetic Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Newborn and Prenatal Genetic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newborn and Prenatal Genetic Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Newborn and Prenatal Genetic Testing total market, 2021-2032, (USD Million)

Global Newborn and Prenatal Genetic Testing total market by region & country, CAGR, 2021-2032, (USD Million)

U.S. VS China: Newborn and Prenatal Genetic Testing total market, key domestic companies, and share, (USD Million)

Global Newborn and Prenatal Genetic Testing revenue by player, revenue and market share 2021-2026, (USD Million)

Global Newborn and Prenatal Genetic Testing total market by Type, CAGR, 2021-2032, (USD Million)

Global Newborn and Prenatal Genetic Testing total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Newborn and Prenatal Genetic Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Veritas Genetics, GGA, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Newborn and Prenatal Genetic Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Newborn and Prenatal Genetic Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Newborn and Prenatal Genetic Testing Market, Segmentation by Type:
NGS
Whole Exome Sequencing
Others

Global Newborn and Prenatal Genetic Testing Market, Segmentation by Screening Purpose:
Core Condition Screening
Expanded Condition Screening

Global Newborn and Prenatal Genetic Testing Market, Segmentation by Service Model:
Public Health Program
Consumer
Others

Global Newborn and Prenatal Genetic Testing Market, Segmentation by Application:
Public Hospitals
Private Hospitals

Companies Profiled:
Thermo Fisher Scientific
Revvity
Quest Diagnostics
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Veritas Genetics
GGA
Cordlife
Rainbow Genomics
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology

Key Questions Answered

1. How big is the global Newborn and Prenatal Genetic Testing market?

2. What is the demand of the global Newborn and Prenatal Genetic Testing market?

3. What is the year over year growth of the global Newborn and Prenatal Genetic Testing market?

4. What is the total value of the global Newborn and Prenatal Genetic Testing market?

5. Who are the Major Players in the global Newborn and Prenatal Genetic Testing market?

6. What are the growth factors driving the market demand? Show more